Výsledky vyhledávání

Abstract 2272: Targeting the chaperone Hsp90 to activate the immune system and eradicate the triple negative breast cancer

Autor: Nada Eisa, Vincent M. Crowley, Asif Elahi, Vamsi K. Kommalapati, Hasan Korkaya, Abdessamad Debbab, Brian Blagg, Ahmed Chadli

Publikováno v: Cancer Research. 83:2272-2272

Low response rates and immune-related adverse events limit the impact of cancer immunotherapy. To improve clinical outcomes, preclinical studies have shown that combining immunotherapies with N-terminal Hsp90 inhibitors resulted in improved efficacy,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c022b97a59c124eb3ad9f0b1bfdb6a0b
https://doi.org/10.1158/1538-7445.am2023-2272

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání